Legend Biotech (LEGN) Asset Writedowns and Impairment (2020 - 2025)
Legend Biotech (LEGN) posted Asset Writedowns and Impairment of $865000.0 for Q3 2025, up 180.99% on a QoQ basis from -$1.1 million in Q2 2025, and up 114.64% year-over-year from $403000.0 in Q3 2024.
Legend Biotech (LEGN) Asset Writedowns and Impairment (2020 - 2025) Analysis & Trends
Legend Biotech's Asset Writedowns and Impairment history runs 5 years deep, the most recent figure standing at $865000.0 for Q3 2025.
- Quarterly Asset Writedowns and Impairment rose 114.64% year-over-year to $865000.0 in Q3 2025, while the trailing twelve-month figure through Sep 2025 was -$6.4 million (down 216.81% YoY) and the FY2024 annual result came in at $4.4 million, changed N/A from the prior year.
- Asset Writedowns and Impairment was $865000.0 for Q3 2025 at Legend Biotech, up from -$1.1 million in the prior quarter.
- Across five years, Asset Writedowns and Impairment topped out at $4.7 million in Q2 2024 and bottomed at -$3.8 million in Q1 2025.
- A 4-year average of $32461.5 and a median of $226000.0 in 2023 frame the typical range for Asset Writedowns and Impairment.
- Annual changes were most pronounced in 2024 — Asset Writedowns and Impairment soared 1965.49% — and 2025, when it plunged 316.16%.
- Legend Biotech's Asset Writedowns and Impairment stood at $22000.0 in 2021, then plunged by 6209.09% to -$1.3 million in 2023, then plunged by 78.94% to -$2.4 million in 2024, then soared by 135.97% to $865000.0 in 2025.
- Business Quant data shows LEGN's Asset Writedowns and Impairment at $865000.0 in Q3 2025, -$1.1 million in Q2 2025, and -$3.8 million in Q1 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 67,072.09 Bn | 67,072.09 Bn | - |
| 2 | Nanobiotix | 1,894.61 Bn | 1,894.55 Bn | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - |
| 4 | BeOne Medicines | 471.64 Bn | 466.85 Bn | 1.35 Bn |
| 5 | Vertex Pharmaceuticals | 121.72 Bn | 114.47 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 68.28 Bn | 59.52 Bn | 3.31 Bn |
| 7 | Belite Bio | 61.40 Bn | 61.40 Bn | - |
| 8 | Argenx Se | 56.94 Bn | 56.94 Bn | 1.18 Bn |
| 9 | Revolution Medicines | 37.37 Bn | 37.37 Bn | - |
| 10 | Legend Biotech | 8.26 Bn | 7.36 Bn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2025 | 865,000.00 |
| Sep 30, 2025 | 865,000.00 |
| Jun 30, 2025 | -1.07 Mn |
| Jun 30, 2025 | -1.07 Mn |
| Mar 31, 2025 | -3.80 Mn |
| Mar 31, 2025 | -3.80 Mn |
| Dec 31, 2024 | -2.41 Mn |
| Dec 31, 2024 | -2.41 Mn |
| Sep 30, 2024 | 403,000.00 |
| Sep 30, 2024 | 403,000.00 |
| Jun 30, 2024 | 4.67 Mn |
| Jun 30, 2024 | 4.67 Mn |
| Mar 31, 2024 | 1.76 Mn |
| Mar 31, 2024 | 1.76 Mn |
| Dec 31, 2023 | -1.34 Mn |
| Dec 31, 2023 | -1.34 Mn |
| Sep 30, 2023 | 767,000.00 |
| Sep 30, 2023 | 767,000.00 |
| Jun 30, 2023 | 226,000.00 |
| Jun 30, 2023 | 226,000.00 |